107 related articles for article (PubMed ID: 29392701)
1. Bioluminescent In Vivo Imaging of Orthotopic Glioblastoma Xenografts in Mice.
Frenster JD; Placantonakis DG
Methods Mol Biol; 2018; 1741():191-198. PubMed ID: 29392701
[TBL] [Abstract][Full Text] [Related]
2. Orthotopic Patient-Derived Glioblastoma Xenografts in Mice.
Xu Z; Kader M; Sen R; Placantonakis DG
Methods Mol Biol; 2018; 1741():183-190. PubMed ID: 29392700
[TBL] [Abstract][Full Text] [Related]
3. Fluorescence and Bioluminescence Imaging of Orthotopic Brain Tumors in Mice.
McKinnon E; Moore A; Dixit S; Zhu Y; Broome AM
Methods Mol Biol; 2017; 1530():283-305. PubMed ID: 28150209
[TBL] [Abstract][Full Text] [Related]
4. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging-guided intracranial resection of glioblastoma tumors in patient-derived orthotopic xenografts leads to clinically relevant tumor recurrence.
Oudin A; Moreno-Sanchez PM; Baus V; Niclou SP; Golebiewska A
BMC Cancer; 2024 Jan; 24(1):3. PubMed ID: 38166949
[TBL] [Abstract][Full Text] [Related]
6. Quantitative in vivo bioluminescence imaging of orthotopic patient-derived glioblastoma xenografts.
Koessinger AL; Koessinger D; Stevenson K; Cloix C; Mitchell L; Nixon C; Gomez-Roman N; Chalmers AJ; Norman JC; Tait SWG
Sci Rep; 2020 Sep; 10(1):15361. PubMed ID: 32958777
[TBL] [Abstract][Full Text] [Related]
7. MicroPET/CT imaging of an orthotopic model of human glioblastoma multiforme and evaluation of pulsed low-dose irradiation.
Park SS; Chunta JL; Robertson JM; Martinez AA; Oliver Wong CY; Amin M; Wilson GD; Marples B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):885-92. PubMed ID: 21489704
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
9. Intracranial implantation with subsequent 3D in vivo bioluminescent imaging of murine gliomas.
Abdelwahab MG; Sankar T; Preul MC; Scheck AC
J Vis Exp; 2011 Nov; (57):e3403. PubMed ID: 22158303
[TBL] [Abstract][Full Text] [Related]
10. Immunohistopathological and neuroimaging characterization of murine orthotopic xenograft models of glioblastoma multiforme recapitulating the most salient features of human disease.
Radaelli E; Ceruti R; Patton V; Russo M; Degrassi A; Croci V; Caprera F; Stortini G; Scanziani E; Pesenti E; Alzani R
Histol Histopathol; 2009 Jul; 24(7):879-91. PubMed ID: 19475534
[TBL] [Abstract][Full Text] [Related]
11. Analyses of Tumor Burden In Vivo and Metastasis Ex Vivo Using Luciferase-Expressing Cancer Cells in an Orthotopic Mouse Model of Neuroblastoma.
Byrne FL; McCarroll JA; Kavallaris M
Methods Mol Biol; 2016; 1372():61-77. PubMed ID: 26530915
[TBL] [Abstract][Full Text] [Related]
12. Optical imaging of luminescence for in vivo quantification of gene electrotransfer in mouse muscle and knee.
Bloquel C; Trollet C; Pradines E; Seguin J; Scherman D; Bureau MF
BMC Biotechnol; 2006 Mar; 6():16. PubMed ID: 16524461
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme.
Baumann BC; Dorsey JF; Benci JL; Joh DY; Kao GD
J Vis Exp; 2012 Sep; (67):. PubMed ID: 23051742
[TBL] [Abstract][Full Text] [Related]
14. Optical and nuclear imaging of glioblastoma with phosphatidylserine-targeted nanovesicles.
Blanco VM; Chu Z; LaSance K; Gray BD; Pak KY; Rider T; Greis KD; Qi X
Oncotarget; 2016 May; 7(22):32866-75. PubMed ID: 27096954
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence Molecular Tomography for In Vivo Imaging of Glioblastoma Xenografts.
Benitez JA; Zanca C; Ma J; Cavenee WK; Furnari FB
J Vis Exp; 2018 Apr; (134):. PubMed ID: 29757276
[TBL] [Abstract][Full Text] [Related]
16. In vivo bioluminescence imaging validation of a human biopsy-derived orthotopic mouse model of glioblastoma multiforme.
Jarzabek MA; Huszthy PC; Skaftnesmo KO; McCormack E; Dicker P; Prehn JH; Bjerkvig R; Byrne AT
Mol Imaging; 2013 May; 12(3):161-72. PubMed ID: 23490442
[TBL] [Abstract][Full Text] [Related]
17. In Vivo Bioluminescent Imaging of Marburg Virus in a Rodent Model.
Lei S; Huang W; Wang Y; Liu Q
Methods Mol Biol; 2020; 2081():177-190. PubMed ID: 31721125
[TBL] [Abstract][Full Text] [Related]
18. Fluorescence-guided resection of experimental malignant glioma using cetuximab-IRDye 800CW.
Warram JM; de Boer E; Korb M; Hartman Y; Kovar J; Markert JM; Gillespie GY; Rosenthal EL
Br J Neurosurg; 2015; 29(6):850-8. PubMed ID: 26073144
[TBL] [Abstract][Full Text] [Related]
19. Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice.
Burgos JS; Rosol M; Moats RA; Khankaldyyan V; Kohn DB; Nelson MD; Laug WE
Biotechniques; 2003 Jun; 34(6):1184-8. PubMed ID: 12813886
[TBL] [Abstract][Full Text] [Related]
20. Biotinylated Bioluminescent Probe for Long Lasting Targeted in Vivo Imaging of Xenografted Brain Tumors in Mice.
Jiang YL; Zhu Y; Moore AB; Miller K; Broome AM
ACS Chem Neurosci; 2018 Jan; 9(1):100-106. PubMed ID: 28532151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
